The National Kidney Foundation (NKF)’s NKF Innovation Fund invested in ZeitLife Transplant Innovations, Inc., a global medical device company specializing in advancing technologies to modernize kidney preservation and logistics.
The amount of the deal was not disclosed.
Led by Ron Mills, CEO, ZeitLife is a global medical device company advancing technologies to modernize kidney preservation and logistics. It brings specialized engineering, industrial design, clinical insights, scaled manufacturing, and commercial expertise to address the challenges and promises in kidney transplantation. The company is at the forefront of advancing preservation fluid and machine perfusion technologies, with a focus on the urgent challenges in organ transportation and logistics. Their specialized expertise and commitment to serial entrepreneurship in the field position them to drive the sharing of organs over longer distances, ensuring universal compliance with solidly established clinical evidence.
By introducing efficient new business models and routine workflows, ZeitLife is accelerating the modernization of the procurement and transplant system.
The NKF’s Innovation Fund has a track record of supporting innovative companies, including Klinrisk, and Diatiro.
FinSMEs
19/11/2023